These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


314 related items for PubMed ID: 11380825

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.
    Franco M, Martínez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodríguez-Iturbe B.
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R251-6. PubMed ID: 17475676
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension.
    Bravo Y, Quiroz Y, Ferrebuz A, Vaziri ND, Rodríguez-Iturbe B.
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F616-23. PubMed ID: 17567935
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis.
    Vanegas V, Ferrebuz A, Quiroz Y, Rodríguez-Iturbe B.
    Kidney Int; 2005 Sep; 68(3):1161-70. PubMed ID: 16105047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
    Yang CW, Ahn HJ, Kim WY, Li C, Jung JY, Yoon SA, Kim YS, Cha JH, Kim J, Bang BK.
    Transplantation; 2003 Feb 15; 75(3):309-15. PubMed ID: 12589150
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of renal perfusion pressure versus angiotensin II on renal oxidative stress in angiotensin II-induced hypertensive rats.
    Polichnowski AJ, Jin C, Yang C, Cowley AW.
    Hypertension; 2010 Jun 15; 55(6):1425-30. PubMed ID: 20404214
    [Abstract] [Full Text] [Related]

  • 14. Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent.
    Lombardi DM, Viswanathan M, Vio CP, Saavedra JM, Schwartz SM, Johnson RJ.
    Nephron; 2001 Jan 15; 87(1):66-74. PubMed ID: 11174028
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impaired pressure natriuresis resulting in salt-sensitive hypertension is caused by tubulointerstitial immune cell infiltration in the kidney.
    Franco M, Tapia E, Bautista R, Pacheco U, Santamaria J, Quiroz Y, Johnson RJ, Rodriguez-Iturbe B.
    Am J Physiol Renal Physiol; 2013 Apr 01; 304(7):F982-90. PubMed ID: 23364804
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo.
    Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB.
    Kidney Int; 2000 Jul 01; 58(1):251-9. PubMed ID: 10886570
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats.
    Guan Z, Giddens MI, Osmond DA, Cook AK, Hobbs JL, Zhang S, Yamamoto T, Pollock JS, Pollock DM, Inscho EW.
    Am J Physiol Renal Physiol; 2013 Mar 15; 304(6):F801-7. PubMed ID: 23269644
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.
    Wenzel UO, Thaiss F, Helmchen U, Stahl RA, Wolf G.
    Kidney Int; 2002 Mar 15; 61(3):1020-9. PubMed ID: 11849457
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.